Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction

JAMA Oncology - United States
doi 10.1001/jamaoncol.2017.0231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Abiraterone Acetate for Early Stage Metastatic Prostate Cancer: Patient Selection and Special Considerations

Therapeutics and Clinical Risk Management
2018English

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients With Castration Resistant Prostate Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Remarkable Response to Abiraterone Acetate in Castration-Resistant Prostate Cancer Patient With Aggressive Liver Metastasis

IJU Case Reports
2018English

A Prognostic Model for Stratifying Clinical Outcomes in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

Canadian Urological Association Journal
Urology
2017English

Prostate-Specific Antigen Decline After 4 Weeks of Treatment With Abiraterone Acetate and Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer

European Urology
Urology
2016English

Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New Onset Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

A Phase 2 Trial of Abiraterone Acetate Without Glucocorticoids for Men With Metastatic Castration-Resistant Prostate Cancer

Cancer
Cancer ResearchOncology
2018English

The First Experience in Using Abiraterone Acetate in Patients With Castration-Refractory Prostate Cancer

Andrologia i Genital'naa Hirurgia
SurgeryReproductive MedicineUrology
2015English

Mp50-20 Impact of Abiraterone Acetate in Prostate Specific Antigen Trial Update: Effect of Abiraterone Acetate and Low Dose Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients With Non-Metastatic Castration-Resistant Prostate Cancer

Journal of Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy